Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck begins tender offer to acquire Idenix
The Fly on the Wall
Friday, June 20, 2014 - 9:41am
tags:
Merck, Idenix, M&A
FDA asks for wider warning on testosterone products
Yahoo/Reuters
Friday, June 20, 2014 - 9:41am
tags:
FDA, testosterone, AbbVie, Endo Health Solutions
AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies
Seeking Alpha
Friday, June 20, 2014 - 9:40am
tags:
AbbVie, Shire, taxes, M&A
IPO Preview: Kite Pharma
Seeking Alpha
Friday, June 20, 2014 - 9:39am
tags:
IPOs, Kite Pharma, cancer immunotherapy
3 Key Opportunities for Medtronic and Covidien
Motley Fool
Friday, June 20, 2014 - 9:37am
tags:
Medtronic, devices, emerging markets, Covidien
AbbVie Offered $46.5 Billion for Shire as Bid Rejected
Bloomberg
Friday, June 20, 2014 - 9:36am
tags:
Shire, AbbVie, M&A
Will Allergan scramble for Shire to beat off Valeant's hostile advance?
Fierce Pharma
Thursday, June 19, 2014 - 5:47pm
tags:
Allergan, Shire, Valeant Pharmaceuticals, M&A
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thursday, June 19, 2014 - 5:47pm
tags:
NUVIGIL, patents, Teva Pharmaceuticals, Sandoz, Apotex, Mylan Labs, Actavis, Lupin
Isis Could Get a $2 Billion Gain From Heart Attack Trials
Bloomberg
Thursday, June 19, 2014 - 5:44pm
tags:
heart attack, Isis Pharmaceuticals, ISIS-APOCIIIRx
Is Pfizer Putting the Car-T Before the Horse?
Motley Fool
Thursday, June 19, 2014 - 5:43pm
tags:
Pfizer, CAR-T, Cellectis
Cubist Readies For Takeoff With New Antibiotic Launch
Investors.com
Thursday, June 19, 2014 - 5:39pm
tags:
antibiotics, Cubist Pharmaceuticals, Sivextro
The Case For and Against Valeant Pharmaceuticals
Motley Fool
Thursday, June 19, 2014 - 11:38am
tags:
Valeant Pharmaceuticals, M&A, Allergan
15 Highest-Paid Biopharma CEOs of 2013
Fierce Pharma
Thursday, June 19, 2014 - 11:36am
tags:
executive pay
FDA takes on Twitter and other online etiquette for medtech makers
Mass Device
Thursday, June 19, 2014 - 11:08am
tags:
FDA, social media, devices
Dr. Reddy’s to Invest in Biologics, Proprietary Medicines
Bloomberg
Thursday, June 19, 2014 - 11:07am
tags:
Dr Reddy's, India
Study: Suicides rise in wake of 'black box' warnings on antidepressants
Fierce Pharma
Thursday, June 19, 2014 - 10:55am
tags:
antidepressants, suicide, black box
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thursday, June 19, 2014 - 10:36am
tags:
NICE, Pradaxa, Xarelto, bloodthinners, Eliquis, Bayer, JNJ, Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim
StemCells early AMD data a 'best case' outcome, says Maxim
The Fly on the Wall
Thursday, June 19, 2014 - 10:19am
tags:
StemCells, dry age-related macular degeneration
Is This MannKind's Biggest Risk?
Motley Fool
Thursday, June 19, 2014 - 9:22am
tags:
MannKind, diabetes, Afrezza
Prestigious Cancer Hospital Rebukes Northwest Bio for 'Inappropriate' Data Disclosures
TheStreet.com
Thursday, June 19, 2014 - 8:55am
tags:
Northwest Biotherapeutics, MD Anderson Cancer Center, DCVax Direct

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.